Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide

3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide is listed in the pharmaceutical impurity collection under CAS 937642-75-6. Its represented structure has formula C14H13ClN2O and a calculated molecular weight of 260.72 g/mol.

2D chemical structure

H 2 N O N C l

Chemical identity

Catalog name
3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide
Common name
Not available
Chemical name
3-[2-(3-chlorophenyl)ethyl]pyridine-2-carboxamide
CAS
937642-75-6
SMILES
NC(=O)c1ncccc1CCc1cccc(Cl)c1
InChI
InChI=1S/C14H13ClN2O/c15-12-5-1-3-10(9-12)6-7-11-4-2-8-17-13(11)14(16)18/h1-5,8-9H,6-7H2,(H2,16,18)
InChIKey
VJHDALMAOZECTJ-UHFFFAOYSA-N
Associated API
Matrix - API Family Loratadine

Record ID: Ae5ab402e8dd9

Computed properties

C14H13ClN2O Molecular formula
260.724 g/molMolecular weight
260.0716 DaMonoisotopic exact mass
55.98 ŲTopological polar surface area
2.6191 Calculated LogP (Wildman–Crippen)
71.6149 cm³/molMolar refractivity (Wildman–Crippen)
2 countHydrogen-bond acceptors
1 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 2 4 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C Cl H N O 0 3 6 9 12 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight260.72432.87
Calculated LogP (Wildman–Crippen)2.619154.55
Topological polar surface area55.9836.98
Hydrogen-bond acceptors215.92
Hydrogen-bond donors138.08
Rotatable bonds (strict)449.39

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC14H13ClN2Odimensionless
Molecular weight260.724g/mol
Monoisotopic exact mass260.0716Da
Topological polar surface area55.98Ų
Calculated LogP (Wildman–Crippen)2.6191dimensionless
Molar refractivity (Wildman–Crippen)71.6149cm³/mol
Hydrogen-bond acceptors2count
Hydrogen-bond donors1count
Rotatable bonds (strict)4count
Heavy atoms18count
Heteroatoms4count
Rings2count
Aromatic rings2count
Aliphatic rings0count
Saturated rings0count
Aromatic heterocycles1count
Aliphatic heterocycles0count
Saturated heterocycles0count
Aromatic carbocycles1count
Aliphatic carbocycles0count
Fraction of sp³ carbon atoms0.1429fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters0count
Unspecified atom stereocenters0count
Spiro atoms0count
Bridgehead atoms0count
Labute approximate surface area110.6077Ų
Valence electrons92count
Radical electrons0count
Bertz complexity569.2254index
Balaban J2.1313index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for 3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide

Qualification and safety assessment of 3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide

Explore toxicological qualification of 3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide and ICH M7 mutagenic impurity assessment of 3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for 3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide and acceptable intake and limit justification for 3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for 3-[2-(3-Chlorophenyl)ethyl]-2-pyridinecarboxamide

Explore Altox services and software through the Altox Pharma-Hub.